kevin_tulsa — that is really helpful context on Oral GLP-1 pipeline. Follow-up question: did you experience any side effects during this phase?
I am in a similar situation (about to start) and trying to set realistic expectations.
To answer KetoKyle's question specifically:
From a clinical standpoint, Oral GLP-1 pipeline overview is something I discuss with patients regularly.
The short answer: discuss this specific situation with your prescribing provider.
The longer answer involves weighing the risk-benefit ratio for your individual situation, which I am happy to elaborate on if helpful.
SteveThurs — wow. I've been looking for this exact info for weeks.
Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.
Verify Your PeptidesEst. 1998. The synthesis house behind the vials you send for testing. ISO 9001 and cGMP certified, 1,500+ staff, batch-specific COA with every order.
Browse GL BiochemAdding my data to this Oral GLP-1 pipeline discussion:
| Metric | Baseline | Month 5 | Month 6 |
|---|---|---|---|
| Weight | 264 lbs | 249 lbs | 209 lbs |
| A1C | 6.8% | 6.0% | 5.2% |
| hsCRP | 8.0 | 4.0 | 0.6 |
Protocol: Semaglutide 1.7mg/wk, resistance training 3x/wk, protein 1.6g/kg/day.
Slightly tangential to Oral GLP-1 pipeline but SteveThurs reminded me — has the insurance landscape changed recently?
I know it is not exactly on-topic but it seems related enough to ask here rather than starting a new thread. Apologies if this has been covered — I did search first.